Product Description
Capitalise on the illustrious therapeutic value of RENTILO TAB & KAMODIUM CAP, an enlightened offer from ELKOS Healthcare Pvt. Ltd. RENTILO TAB, containing Teneligliptin 20 mg, is highly recommended for managing Type 2 Diabetes Mellitus, delivering commanding control over blood sugar. KAMODIUM CAP, with Racecadotril 100 mg, is designed for acute diarrhea relief in adults. Both products are available by prescription only, exemplifying stringent pharmaceutical standards. Shelf life extends for 24 months. Use exclusively under medical supervision to mitigate potential gastrointestinal side effects. Store in a cool, dry, and dark place. Pricing as per local guidelines.
Versatile Use and Targeted Applications
RENTILO TAB is an oral hypoglycemic agent used for controlling high blood sugar in adults diagnosed with Type 2 Diabetes Mellitus. KAMODIUM CAP, on the other hand, serves as a commanding antidiarrheal agent, suitable for treating acute diarrhea in adults. These allopathic medicines are highly recommended for use in retail pharmacies across India, addressing critical healthcare needs in metabolic and gastrointestinal domains with assured efficacy.
Sample Policy, Payment, and Supply Proposals
Sample policies for RENTILO TAB & KAMODIUM CAP can be discussed upon requestproposal amounts may vary depending on volume. Payment terms are generally flexible, tailored to retailer requirements to facilitate smooth transactions. Products are supplied in robust packaging (10x10 strips per box) and are swiftly handed over based on confirmed orders. Steadfast supply ability ensures timely delivery to meet ongoing demand, making ELKOS Healthcare a reliable exporter, manufacturer, and supplier in the pharmaceutical industry.
FAQs of RENTILO TAB & KAMODIUM CAP:
Q: How should RENTILO TAB and KAMODIUM CAP be stored for optimal efficacy?
A: Both products should be stored in a cool, dry, and dark place, protected from moisture, to ensure maximum shelf life and effectiveness.
Q: What is the recommended usage of RENTILO TAB for Type 2 Diabetes?
A: RENTILO TAB is commonly prescribed once daily for adults with Type 2 Diabetes, but the exact dosage must follow a registered medical practitioners guidance.
Q: When is KAMODIUM CAP indicated for use?
A: KAMODIUM CAP is prescribed for the management of acute diarrhea in adults and should be taken as directed by a physician, commonly before meals.
Q: Are there any possible side effects associated with these medications?
A: Yes, both products should be used under medical supervision as they may cause gastrointestinal disturbances or other side effects in certain individuals.
Q: What areas or conditions do RENTILO TAB & KAMODIUM CAP primarily address?
A: RENTILO TAB targets high blood sugar control in Type 2 diabetes, whereas KAMODIUM CAP is designed for the rapid relief of acute diarrhea in adults.
Q: How can retailers obtain samples and discuss supply agreements?
A: Interested retailers can request sample policies and discuss proposal amounts directly with ELKOS Healthcare Pvt. Ltd. Payment terms and supply ability are arranged to meet client needs.